STORM Therapeutics
PrivateLast Round
Series C
Apr 16, 2026
Est. Valuation
$50.5M
Total Funding Raised
$126.42M
Momentum
Top 10%
of companies Caplight tracks
Company Overview
STORM Therapeutics is a biotechnology company that develops small molecule therapies targeting RNA modifying enzymes for the treatment of cancer and other immune diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery, Clinical Trials, Precision Medicine
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
STORM Therapeutics Comps
Public and private peers based on sector, stage, and business model.
| Company | Status | Est. Valuation | Rev Multiple |
|---|---|---|---|
| OpenAI | Private | $86.0B | ~40x |
| Cohere | Private | $5.0B | -- |
| Competitor 1 | Public | $XX.XB | XXx |
| Competitor 2 | Public | $XX.XB | XXx |
STORM Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Series C | Apr 16, 2026 | ||||
| Series B | Dec 14, 2022 | ||||
| Grant | May 3, 2022 | ||||
| Series A Extension | May 20, 2019 | ||||
| Grant | Sep 3, 2018 | ||||
Series A Extension | Jan 8, 2018 |
STORM Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Innovate UK | Grant |
| IP Group | Series B, Series A Extension, Series C |
| Seroba Life Sciences | Series B, Series A Extension |
| Taiho Ventures | Series A Extension, Series C, Series B |
| M Ventures | Series A Extension, Series C, Series A, Series B |
| UKRI Innovate UK | Grant |
| Merck KGaA | Series B, Series A Extension, Series A |
Market signals
Structured signals derived from secondary market and firmographic data.
- Apr 16, 2026
$56M round completed.
- Feb 12, 2026
Collaborating with Sygnature Discovery on DHX9 inhibitor program.
STORM Therapeutics Filings
SEC and related filings with document metadata.
| Typed | Date | Amount Offered | Amount Sold | Filling | Pages | Download |
|---|---|---|---|---|---|---|
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation | Sign Up to view | Mock Valuation |
Frequently Asked Questions
Common questions about STORM Therapeutics's valuation, stock price, and market status.